EFNCB1, ERF, FGFR1, FGFR2, FGFR3, MSX2, POR, RAB23, RECQL4, TCF, TWIST1
Craniosynostosis NGS Panel
Key Information
Lab:
TAT:
35 days
Price:
$2,500
CPT Code(s):
81479
Test Code:
DCRA
Prenatal Samples Accepted
Craniosynostosis NGS Panel
The Craniosynostosis NGS Panel is an 8-gene panel intended for patients with a diagnosis or clinical suspicion of craniosynostosis.
Craniofrontonasal dysplasia, Craniosynostosis, Crouzon with acanthosis nigricans, Muenke syndrome, Saethre-Chotzen syndrome
Clinical Information
Craniosynostosis involves premature or disordered suture closure resulting in skull asymmetry. This condition occurs in approximately 1 in 2500 births, and most are inherited from an affected parent or occur as a de novo autosomal dominant variant. However, a few of these conditions result from autosomal recessive inheritance including Antley-Bixler, Carpenter, and Baller-Gerold syndromes. Craniosynostosis syndromes exhibit genetic heterogeneity as well as phenotypic variability with features that may include facial dysmorphism, palatal abnormalities, short stature, proptosis, and developmental delays. Craniosynostosis may also occur as an isolated finding. The 8 genes included on this panel account for multiple distinct clinical phenotypes.
Technical Information
This panel is performed by Next Generation Sequencing and covers the coding regions of the listed genes and the flanking intronic sequences. Promoter, 3′ untranslated sequences, and deep intronic sequences are also covered, but only known disease-causing variants in these regions will be reported. Variants identified on the panel are confirmed with Sanger sequencing if they do not meet certain quality thresholds.
Large deletions and duplications (CNVs) affecting the genes of the panel can be detected; however, due to defined settings in the analysis software, CNVs smaller than 2-kb may not be identified (for example, some small exonic level copy number changes may not be identified). Please note that certain types of genetic alterations including trinucleotide repeat expansions, methylation abnormalities, and balanced rearrangements (e.g., inversions, reciprocal translocations) may not be detected by the current analysis.
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis may be available if there are clinical features identified on ultrasound suggestive of craniosynostosis. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
